Cancer BiologybioRxivPreprint
Tamoxifen and Doxorubicin Synergistically Target Estrogen Receptor beta-Mutant p53-p73 Axis, a Therapeutically Actionable Vulnerability in Triple Negative Breast Cancer
Chetan C. Oturkar, Junhoung Park J, Iqbal Ijaz…·Gokul M. Das
This paper shows that Tamoxifen and Doxorubicin together target the ER beta-mutant p53-p73 axis in TNBC, enhancing cell death through apoptosis and ferroptosis.
DOI 10.64898/2026.10.21.760572